BioCentury | Feb 9, 2009
Product Development

Aiming to be photogenic

Clinuvel Pharmaceuticals Ltd. spent the first half of this decade looking for a therapeutic application for its afamelanotide, which it knew worked as a photoprotectant and which the media had tagged as a potential tanning...
BioCentury | Oct 8, 2007
Politics, Policy & Law

Politics & Policy

The problem with single-payer healthcare systems with fixed budgets like the U.K.'s National Health Service is that they are zero-sum games: to pay for one new drug that comes on the market, something else has...
BioCentury | Oct 24, 2005
Company News

PharmaFrontiers board of directors update

...Corp. (PFTR), The Woodlands, Texas Business: Autoimmune, Gene/Cell therapy Appointed: Brooks Boveroux, retired CFO of Imcor Pharmaceutical Co. WIR...
BioCentury | Oct 17, 2005
Company News

Alliance management update

...Calif. Business: Hematology Hired: Jack DeFranco as president and COO, formerly SVP and COO of Imcor Pharmaceutical Co. WIR...
BioCentury | Oct 3, 2005
Company News

Alliance, General Electric, Imcor Pharmaceutical diagnostic news

...its licenses. Alliance Pharmaceutical Corp. (ALLP), San Diego, Calif. General Electric Co. (GE), Fairfield, Conn. Imcor Pharmaceutical Co....
BioCentury | Feb 28, 2005
Company News

Imcor Pharmaceutical management update

Imcor Pharmaceutical Co. (ICPH), San Diego, Calif. Business: Imaging Promoted: Jack DeFranco to SVP and COO, from SVP of business development and marketing WIR Staff...
BioCentury | Feb 7, 2005
Company News

Imcor Pharmaceutical board of directors update

Imcor Pharmaceutical Co. (ICPH), San Diego, Calif. Business: Imaging Appointed: Robert Ashley, president, chairman and CEO of AmpliMed Corp. WIR Staff...
BioCentury | Feb 7, 2005
Strategy

Genencor chronicles

...vaccines against HBV, HCV, and HPV. E. 8/14/01 - Licenses VP22 vaccine delivery technology from Photogen...
BioCentury | Dec 13, 2004
Clinical News

Imagent: Started Phase II

...ICPH began an open-label, dose-ranging, U.S. Phase II study in up to 50 patients. Imcor Pharmaceutical Co. (ICPHC...
BioCentury | Oct 4, 2004
Company News

Imcor Pharmaceutical management update

Imcor Pharmaceutical Co. (ICPH), San Diego, Calif. Business: Imaging Departed: Brooks Boveroux as CFO and secretary; CEO Taffy Williams will serve as acting CFO WIR Staff...
Items per page:
1 - 10 of 39
BioCentury | Feb 9, 2009
Product Development

Aiming to be photogenic

Clinuvel Pharmaceuticals Ltd. spent the first half of this decade looking for a therapeutic application for its afamelanotide, which it knew worked as a photoprotectant and which the media had tagged as a potential tanning...
BioCentury | Oct 8, 2007
Politics, Policy & Law

Politics & Policy

The problem with single-payer healthcare systems with fixed budgets like the U.K.'s National Health Service is that they are zero-sum games: to pay for one new drug that comes on the market, something else has...
BioCentury | Oct 24, 2005
Company News

PharmaFrontiers board of directors update

...Corp. (PFTR), The Woodlands, Texas Business: Autoimmune, Gene/Cell therapy Appointed: Brooks Boveroux, retired CFO of Imcor Pharmaceutical Co. WIR...
BioCentury | Oct 17, 2005
Company News

Alliance management update

...Calif. Business: Hematology Hired: Jack DeFranco as president and COO, formerly SVP and COO of Imcor Pharmaceutical Co. WIR...
BioCentury | Oct 3, 2005
Company News

Alliance, General Electric, Imcor Pharmaceutical diagnostic news

...its licenses. Alliance Pharmaceutical Corp. (ALLP), San Diego, Calif. General Electric Co. (GE), Fairfield, Conn. Imcor Pharmaceutical Co....
BioCentury | Feb 28, 2005
Company News

Imcor Pharmaceutical management update

Imcor Pharmaceutical Co. (ICPH), San Diego, Calif. Business: Imaging Promoted: Jack DeFranco to SVP and COO, from SVP of business development and marketing WIR Staff...
BioCentury | Feb 7, 2005
Company News

Imcor Pharmaceutical board of directors update

Imcor Pharmaceutical Co. (ICPH), San Diego, Calif. Business: Imaging Appointed: Robert Ashley, president, chairman and CEO of AmpliMed Corp. WIR Staff...
BioCentury | Feb 7, 2005
Strategy

Genencor chronicles

...vaccines against HBV, HCV, and HPV. E. 8/14/01 - Licenses VP22 vaccine delivery technology from Photogen...
BioCentury | Dec 13, 2004
Clinical News

Imagent: Started Phase II

...ICPH began an open-label, dose-ranging, U.S. Phase II study in up to 50 patients. Imcor Pharmaceutical Co. (ICPHC...
BioCentury | Oct 4, 2004
Company News

Imcor Pharmaceutical management update

Imcor Pharmaceutical Co. (ICPH), San Diego, Calif. Business: Imaging Departed: Brooks Boveroux as CFO and secretary; CEO Taffy Williams will serve as acting CFO WIR Staff...
Items per page:
1 - 10 of 39